Skip to main content
. 2020 Dec 18;17:1–7. doi: 10.1016/j.phro.2020.12.004

Fig. 1.

Fig. 1

Comparison of clinically relevant dose parameters for automatically generated treatments plans (9 and 12 field IMRT as well as 2 and 3 arc VMAT) and plans manually generated in the previous clinical TPS for anal cancer (n = 14), rectum cancer (n = 9), prostate cancer (n = 8), and bladder cancer (n = 7) patients. The inner line denotes the median value, the box the interquartile range, the whiskers the 9th and 91st percentile, with the outliers presented as single markers.